Article - Pharmaceutical Executive



Capturing the Real Value from a Pharma Business Spinout

July 1, 2014

As companies divest non-core assets in the form of spinouts to unlock value, the role of a strong new parent brand has become increasingly important.

Pharm Exec Industry Audit Slideshow

July 2, 2013

Click here to scan the metrics—including sales growth and gross margins—that PharmExec used to assess company performance and decide on this year's industry audit winner.

Oncology: Pathways to Progress

February 1, 2013

Pharm Exec recently convened a cross-section of industry experts to review current and pending efforts to turn great science into good oncology practice.

The Clinical Data Transparency Rush — Are You For or Against?

December 10, 2012

By Jacky Law.

Pharm Exec's 2013 Pipeline Report

November 1, 2012

Is the 'lost decade' of declining pipeline productivity finally over? Our annual survey of analyst assessments of the state of drug development suggests so...

Who Pays for Specialty Medicines?

November 1, 2012

Providers and patients fish for that delicate balance between access and abandonment.

How Health Analytics Can Improve the Patient Experience

October 29, 2012

Brad Sitler looks at the challenge for pharma of engaging patients and helping physicians provide them with the right information at the right time.

The Undercurrent of the Supreme Court Decision: Money

June 20, 2012

So, it looks like June 25th will be the moment of truth we have all been anticipating. The Supreme Court is expected to hand down its ruling on the 2010 healthcare reform law. Who knows what will happen?

The Pharma Top 20s

June 20, 2012

What were the Top 20 Global Pharma Products for 2011? The Top 20 Global Therapy Areas? Find out in our Pharma Top 20s slide show.


Click here